Institutional investors purchased a net $5.3 million shares of NWBO during the quarter ended June 2016. This may signal that the smart money is gaining interest in this company as the 32.42% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLENNIUM MANAGEMENT LLC Bought 460.3 Thousand shares of Northwest Biotherapeutics...